Please make use of TCI's "Endo-M," "Glycosynthase," and "synthetic oligosaccharides" in the research and development of biopharmaceuticals.
The issue of the heterogeneity of glycan structures in antibody drugs for disease treatment has not been resolved for a long time. We have successfully transferred uniform glycans to antibody drugs using our enzymes "Endo-M" and "Glycosynthase," which we have commercialized. We can provide this in quantities suitable for practical scale. *For more details, please refer to the PDF document or feel free to contact us.*
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（3）
Download All Catalogs
Company information
Our company is a global chemical manufacturer that has been providing high-quality organic reagents for over half a century, guided by our corporate philosophy of "contributing to society through reagents." We supply over 30,000 research and development reagent products, as well as a wide range of raw materials for pharmaceuticals, chemicals, electronic materials, and more. As a manufacturer capable of providing specialized and rare reagents, we actively engage in contract services such as small-scale synthesis, process development, and large-scale production, leveraging our manufacturing technologies accumulated over more than fifty years and our versatile equipment. We have overseas bases in North America, Europe, China, and India, and we operate our business worldwide. Our products are used in over 80 countries.
![[ODM Case] Treatment Assistance Device Impulser](https://image.mono.ipros.com/public/product/image/d53/2001488385/IPROS67049995700314900543.png?w=280&h=280)